PMID- 11916498 OWN - NLM STAT- MEDLINE DCOM- 20020523 LR - 20181023 IS - 1522-8517 (Print) IS - 1523-5866 (Electronic) IS - 1522-8517 (Linking) VI - 4 IP - 2 DP - 2002 Apr TI - Comprehensive molecular cytogenetic investigation of chromosomal abnormalities in human medulloblastoma cell lines and xenograft. PG - 75-85 LID - 10.1093/neuonc/4.2.75 [doi] AB - Cell lines and xenografts derived from medulloblastomas are useful tools to investigate the chromosomal changes in these tumors. Here we used G-banding, fluorescence in situ hybridization (FISH), spectral karyotyping (SKY), and comparative genomic hybridization to study 4 medulloblastoma cell lines and 1 xenograft. Cell line D-425 Med had a relatively simple karyotype, with a terminal deletion of 10q and amplification of MYC in double-minutes (dmins). FISH demonstrated that an apparent isochromosome (17q) by routine karyotyping was actually an unbalanced translocation between 2 copies of chromosome 17. Cell line D-556 Med also had a simple near-diploid stemline with an unbalanced 1;13 translocation resulting in a gain of 1q, an isochromosome (17q), and dmins. These findings were initially described using routine G-banded preparations, and FISH showed that the dmins were an amplification of MYC and the i(17q) was an isodicentric 17q chromosome. The other finding was confirmed by FISH, SKY, and comparative genomic hybridization. Cell lines D-721 Med and D-581 Med had complex karyotypic patterns that could be completely characterized only when FISH and SKY were used. Xenograft D-690 Med also had a complex pattern that FISH and SKY were helpful in completely elucidating. Interestingly, balanced reciprocal translocations were seen as well as complicated unbalanced translocations and marker chromosomes. Comparative genomic hybridization demonstrated only a deletion of 10q22-10q24, supporting the idea that despite the complexity of the chromosomal rearrangements, minimal alterations in the overall chromosomal content had occurred. This study demonstrates that routine cytogenetic preparations are adequate to describe chromosomal abnormalities in occasional medulloblastoma samples, but a broader spectrum of molecular cytogenetic methods is required to completely analyze most of these tumor samples. FAU - Aldosari, Naji AU - Aldosari N AD - Department of Pathology, Duke University Medical Center, Durham, NC 27710, USA. FAU - Wiltshire, Rodney N AU - Wiltshire RN FAU - Dutra, Amalia AU - Dutra A FAU - Schrock, Evelin AU - Schrock E FAU - McLendon, Roger E AU - McLendon RE FAU - Friedman, Henry S AU - Friedman HS FAU - Bigner, Darell D AU - Bigner DD FAU - Bigner, Sandra H AU - Bigner SH LA - eng GR - CA-68119/CA/NCI NIH HHS/United States PT - Journal Article PT - Research Support, U.S. Gov't, P.H.S. PL - England TA - Neuro Oncol JT - Neuro-oncology JID - 100887420 SB - IM MH - Adolescent MH - Cerebellar Neoplasms/*genetics MH - Child, Preschool MH - *Chromosome Aberrations MH - Female MH - Humans MH - In Situ Hybridization, Fluorescence MH - Karyotyping MH - Male MH - Medulloblastoma/*genetics MH - Nucleic Acid Hybridization MH - Transplantation, Heterologous MH - Tumor Cells, Cultured PMC - PMC1920654 EDAT- 2002/03/28 10:00 MHDA- 2002/05/25 10:01 PMCR- 2003/04/01 CRDT- 2002/03/28 10:00 PHST- 2001/07/13 00:00 [received] PHST- 2001/10/08 00:00 [accepted] PHST- 2002/03/28 10:00 [pubmed] PHST- 2002/05/25 10:01 [medline] PHST- 2002/03/28 10:00 [entrez] PHST- 2003/04/01 00:00 [pmc-release] AID - 10.1093/neuonc/4.2.75 [doi] PST - ppublish SO - Neuro Oncol. 2002 Apr;4(2):75-85. doi: 10.1093/neuonc/4.2.75.